Femasys Inc
NASDAQ:FEMY

Watchlist Manager
Femasys Inc Logo
Femasys Inc
NASDAQ:FEMY
Watchlist
Price: 0.56 USD 0.36% Market Closed
Market Cap: $32.7m

Femasys Inc
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Femasys Inc
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Femasys Inc
NASDAQ:FEMY
Inventory
$3m
CAGR 3-Years
144%
CAGR 5-Years
78%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Inventory
$2.9B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Inventory
$5.3B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
12%
Abbott Laboratories
NYSE:ABT
Inventory
$6.7B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
10%
IDEXX Laboratories Inc
NASDAQ:IDXX
Inventory
$391.6m
CAGR 3-Years
2%
CAGR 5-Years
13%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Inventory
$1.8B
CAGR 3-Years
27%
CAGR 5-Years
25%
CAGR 10-Years
27%
No Stocks Found

Femasys Inc
Glance View

Market Cap
32.7m USD
Industry
Health Care

Femasys, Inc. operates as a medical device company that focuses on women's healthcare. The company is headquartered in Suwanee, Georgia. The company went IPO on 2021-06-18. The firm is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The firm has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. FemaSeed is an artificial insemination infertility treatment. The firm also offers FemVue Saline-Air device for diagnosis of infertility and FemCerv Endocervical Sampler for diagnosis of cervical cancer. FemCerv is a sterile, single-use disposable endocervical curettage product that can be used to sample cervical cells and tissue, including in support of further testing following an abnormal Pap test to assess for any problems such as cancer, in a relatively pain-free office procedure.

FEMY Intrinsic Value
0.82 USD
Undervaluation 32%
Intrinsic Value
Price

See Also

What is Femasys Inc's Inventory?
Inventory
3m USD

Based on the financial report for Dec 31, 2024, Femasys Inc's Inventory amounts to 3m USD.

What is Femasys Inc's Inventory growth rate?
Inventory CAGR 5Y
78%

Over the last year, the Inventory growth was 357%. The average annual Inventory growth rates for Femasys Inc have been 144% over the past three years , 78% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett